Navigation Links
Boston Scientific Welcomes Revised Outlook From Fitch Ratings
Date:6/9/2008

NATICK, Mass., June 9 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today welcomed an announcement by Fitch Ratings that it has revised its Rating Outlook on the Company, to Stable from Negative. Fitch also reaffirmed the Company's long-term credit rating of BB+.

Fitch said the revised Outlook is supported by the progress Boston Scientific is making toward stabilizing its drug-eluting stent and cardiac rhythm management businesses, while paying down debt in the process. The Company has paid down $1.7 billion of debt during the past 12 months.

Fitch added that it expects Boston Scientific's leverage will decline further in the intermediate term through increased cash flow growth and debt reduction.

"We welcome this revised outlook and see it as another indication that we are moving in the right direction in a number of key areas," said Sam Leno, Chief Financial Officer of Boston Scientific. "The Fitch action also confirms that our expense and head count reduction plan is being executed effectively and is helping strengthen our financial position."

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: http://www.bostonscientific.com.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar words. Thes
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Boston Scientific to Participate in Goldman Sachs Conference
2. Boston Scientific Announces CEO Jim Tobin to Extend Tenure
3. NanoLogix Inc. to Present at The American Society for Microbiology (ASM) General Meeting in Boston; Announces Product Line and Provides Operations Update
4. Boston Scientific Completes Acquisition of CryoCor
5. Boston Scientific Announces Launch of Expanded Size Range of FilterWire EZ(TM) Embolic Protection System
6. Boston Scientific Announces FDA Approval of New Heart Failure Lead
7. Boston Scientifics SpyGlass(R) Direct Visualization System to Be Prominently Featured at Digestive Disease Week(R)
8. Boston Scientific Announces Program to Analyze Latitude(R) Patient Monitoring Data
9. Boston Scientific Announces European Approval and Market Launch of New Family of Advanced Pacemakers
10. WIPO Panel Rules Boston Scientific Liberte(R) and TAXUS(R) Liberte(R) Stents Do Not Infringe Medinol Patents
11. Fraunhofer and Boston University Hosted Prestigious SME Tour

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...TO, Nov. 6 /PRNewswire-FirstCall/ - Microbix Biosy... has re-filed the Form 52-109F1 Certification of A...ve Officer and James Long, the Chief Financial Off...12, 2009 in connection with the annual audited fin... 2008. ,, The Company initially filed the annua...
(Date:11/6/2009)...Y, Mass., Nov. 6 Myriant Technolog...eloper and manufacturer of renewable bio-chemical...echnology provider Uhde GmbH, one of the world,s l...nnounced an alliance for the engineering, procurem... Succinic Acid plants based on renewable feedstock...
(Date:11/6/2009)...G VALLEY, Calif., Nov. 6 Calbiotec... Small Business Innovative Research (SBIR) Phase I...terial command. Under terms of the agreement, Calb...s) for the diagnosis of Dengue virus. ,, Den...sents a major threat to military forces deployed t...
(Date:11/6/2009)... The agenda for Arrowhead’s 20...which is set to take place on February 22-24, 2010...e day conference we will highlight key issues in f...o share their experiences. , ...e agenda for Arrowhead’s 2010 Personalized ...
Breaking Biology Technology:Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3
...Sales Grow to $10.5 Million in 2007; MOXATAG, Comp...r-end; Process to Explore Strategic ... March 4 MiddleBrook,Pharmaceuticals, Inc. (Nasda...veloping and commercializing novel anti-infective ...l results for the quarter and fiscal year,ended De...
...h 4 SGX Pharmaceuticals,(Nasdaq: SGXP ) will ann...,full year 2007 on Wednesday, March 12, 2008. The ... call and webcast at 8:00 a.m. Pacific Time.,Mike ...odd Myers, Chief,Financial Officer, will host the ...usiness highlights., Interested participants and ...
... teams led by Dr. Michael Verkhovsky and Prof. Mrt...e University of Helsinki have for the first time s...x I in real time. In the future, this work might, ...of the maternally inherited so-called mitochondria... , This achievement required developing and build...
Other Biology Technology:MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 2MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 3MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 4MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 5MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 6MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 7MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 8MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 9MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 10MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 11MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 12MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 13MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 14MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 15SGX Pharmaceuticals Schedules Teleconference and Webcast for Fourth Quarter and Full Year 2007 Results 2Biological electron transfer captured in real time 2
(Date:11/4/2009)... Singapore laboratory that deciphered the DNA code...nd elephant shark, has joined The Genome 10K Proje... repository of DNA sequences on 10,000 species of ...ale that currently can not be achieved. , Partic...paper published in the Nov. 5, 2009 issue of the ...
(Date:11/4/2009)... MADISON, N.J., Oct. 20 ...world,s leading provider of diagnostic testing, in...rd quarter ended September 30, 2009, income from c...2 per diluted share, from $160 million, or $0.81 p...n 2008, third quarter results were reduced by a $0...
(Date:11/4/2009)... RIDGE, N.Y., Oct. 21 What,s the c...venting accidental death resulting from prescripti... with good intentions, however, may be unaware tha...ing their teens from the ticking timebomb of presc...eader in premium-quality medical supplies, has for...
Breaking Biology News(10 mins):Singapore scientists join international study of 10,000 vertebrates' genomes 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3Suicide Genes Help Slow Ovarian Tumor Growth in Mice 53210 1Suicide Genes Help Slow Ovarian Tumor Growth in Mice 53210 2Palomar Medical Reports Financial Results for Second Quarter 2009 53208 1Palomar Medical Reports Financial Results for Second Quarter 2009 53208 2Palomar Medical Reports Financial Results for Second Quarter 2009 53208 3Palomar Medical Reports Financial Results for Second Quarter 2009 53208 4Palomar Medical Reports Financial Results for Second Quarter 2009 53208 5Palomar Medical Reports Financial Results for Second Quarter 2009 53208 6Palomar Medical Reports Financial Results for Second Quarter 2009 53208 7Palomar Medical Reports Financial Results for Second Quarter 2009 53208 8CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 1CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 2CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 3CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 4CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 5CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 6CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 7CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 8CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 9CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 10CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 11CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 12CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 13CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 14CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 15
...rchers have decoded the genetic makeup of the para...ommon sexually transmitted infections (STIs), reve...ecome increasingly drug resistant and suggesting p...nd a potential vaccine strategy. The genome sequen...Allergy and Infectious Diseases (NIAID), part of t...
... there is no cure for lingering viral infections s... University suggests it may be possible to deactiv...genetic switch. , Princeton scientists Leor Weinb...nate the processes by which human immunodeficiency...mant phases in their hosts. The researchers have d...
...ional workplace ban on smoking in Ireland resulted...bs, an 80 percent decrease in airborne carcinogens...respiratory health of bar workers, according to a ...n the second issue for April 2007 of the American ... published by the American Thoracic Society. , ...
Other Biology News:Scientists sequence genome of parasite responsible for common sexually transmitted infection 2Scientists sequence genome of parasite responsible for common sexually transmitted infection 3Scientists find potential 'off-switch' for HIV virus 2Scientists find potential 'off-switch' for HIV virus 3Scientists find potential 'off-switch' for HIV virus 4Smoking ban dramatically reduces air pollution in Irish pubs 2Smoking ban dramatically reduces air pollution in Irish pubs 3
Anti-Endomorphin-2 Polyclonal Antibody, Unconjugated from CHEMICON
...0kb), and large plasmid insert (10-20kb) DNAs. Gre... command 20-50 fold copy amplification for high yi...ble with blue-white screening (pEZ BAC) or transcr...sert stability. Kits include electrocompetent cell...
PCRX Enhancer System from Invitrogen
Goat Anti-MAGP-2 (C-19) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Biology Products: